C62.9 — Malignant neoplasm of testis, unspecified whether descended or undescended
Is C62.9 billable?
No — C62.9 is a non-billable header code. C62.9 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 3 billable codes beneath C62.9.
C62.9 at a glance
| Code | C62.9 |
|---|---|
| Description | Malignant neoplasm of testis, unspecified whether descended or undescended |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
How is C62.9 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to C62.9. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Orchioblastoma
- Seminoma
- Spermatocytoma
- Embryoma › testis
- Teratoma › testis (solid)
- Embryoma › malignant › testis
- Sertoli cell › carcinoma › unspecified site
- Leydig cell › carcinoma › unspecified site › male
- Leydig cell › tumor › malignant › unspecified site › male
Use additional code — inherited from C62
Report an additional code alongside C62.9 to fully describe the condition. C62.9 is sequenced first.
- code to identify any functional activity
What codes fall under C62.9? (3)
How long has C62.9 existed?
C62.9 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.